RT Journal Article
SR Electronic
T1 Patient trajectories among hospitalised COVID-19 patients vaccinated with an mRNA vaccine in Norway: a register-based cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.05.21265958
DO 10.1101/2021.11.05.21265958
A1 Whittaker, Robert
A1 Bråthen Kristofferson, Anja
A1 Valcarcel Salamanca, Beatriz
A1 Seppälä, Elina
A1 Golestani, Karan
A1 Kvåle, Reidar
A1 Watle, Sara Viksmoen
A1 Alnes Buanes, Eirik
YR 2021
UL http://medrxiv.org/content/early/2021/11/09/2021.11.05.21265958.abstract
AB Objectives With most of the Norwegian population vaccinated against COVID-19, an increasing number and proportion of COVID-19 related hospitalisations are occurring among vaccinated patients. To support patient management and capacity planning in hospitals, we estimated the length of stay (LoS) in hospital and odds of intensive care (ICU) admission and in-hospital mortality among COVID-19 patients ≥18 years who had been vaccinated with an mRNA vaccine, compared to unvaccinated patients.Methods Using national registry data, we conducted a cohort study on SARS-CoV-2 positive patients hospitalised in Norway between 1 February and 30 September 2021, with COVID-19 as the main cause of hospitalisation. We used a Cox proportional hazards model to examine the association between vaccination status and LoS. We used logistic regression to examine the association between vaccination status and ICU admission and in-hospital mortality.Results We included 2,361 patients, including 70 (3%) partially vaccinated and 183 (8%) fully vaccinated. Fully vaccinated patients 18–79 years had a shorter LoS in hospital overall (adjusted hazard ratio for discharge: 1.35, 95%CI: 1.07–1.72), and lower odds of ICU admission (adjusted odds ratio: 0.57, 95%CI: 0.33–0.96). Similar estimates were observed when collectively analysing partially and fully vaccinated patients. We observed no difference in the LoS for patients not admitted to ICU, nor odds of in-hospital death between vaccinated and unvaccinated patients.Conclusions Vaccinated patients hospitalised with COVID-19 in Norway have a shorter LoS and lower odds of ICU admission than unvaccinated patients. These findings can support patient management and ongoing capacity planning in hospitals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was granted by Regional Committees for Medical Research Ethics - South East Norway, reference number 249509. The need for informed consent was waived by the ethics committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset analysed in the study contains individual-level linked data from various central health registries, national clinical registries and other national administrative registries in Norway. The researchers had access to the data through the national emergency preparedness registry for COVID-19 (Beredt C19), housed at the Norwegian Institute of Public Health (NIPH). In Beredt C19, only fully anonymised data (i.e. data that are neither directly nor potentially indirectly identifiable) are permitted to be shared publicly. Legal restrictions therefore prevent the researchers from publicly sharing the dataset used in the study that would enable others to replicate the study findings. However, external researchers are freely able to request access to linked data from the same registries from outside the structure of Beredt C19, as per normal procedure for conducting health research on registry data in Norway. Further information on Beredt C19, including contact information for the Beredt C19 project manager, and information on access to data from each individual data source, is available at https://www.fhi.no/en/id/infectious-diseases/coronavirus/emergency-preparedness-register-for-covid-19/.